1-2 of 2
Helen Marr
Close
Sort by
Journal Articles

Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study

Clinical Trials & Observations
Ann Tivey, Rohan Shotton, Toby A. Eyre, David Lewis, Louise Stanton, Rebecca Allchin, Harriet Walter, Fiona Miall, Rui Zhao, Anna Santarsieri, Rory McCulloch, Mark Bishton, Amy Beech, Victoria Willimott, Nicole Fowler, Claudia Bedford, Jack Goddard, Sam Protheroe, Angharad Everden, David Tucker, Josh Wright, Vasavi Dukka, Miriam Reeve, Shankara Paneesha, Mahesh Prahladan, Andrew Hodson, Iman Qureshi, Manasvi Koppana, Mary Owen, Kushani Ediriwickrema, Helen Marr, Jamie Wilson, Jonathan Lambert, David Wrench, Claire Burney, Chloe Knott, Georgina Talbot, Adam Gibb, Angela Lord, Barry Jackson, Simon Stern, Taylor Sutton, Amy Webb, Marketa Wilson, Nicky Thomas, Jane Norman, Elizabeth Davies, Lisa Lowry, Jamie Maddox, Neil Phillips, Nicola Crosbie, Marcin Flont, Emma Nga, Andres Virchis, Raisa Guerrero Camacho, Wunna Swe, Arvind Pillai, Clare Rees, James Bailey, Steve Jones, Susan Smith, Faye Sharpley, Catherine Hildyard, Sajir Mohamedbhai, Toby Nicholson, Simon Moule, Anshuman Chaturvedi, Kim Linton
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1209–1219.
https://doi.org/10.1182/bloodadvances.2023011152
Published: 2024
Includes: Supplemental data
Journal Articles

Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia

Paul Milne, Charlotte Wilhelm-Benartzi, Michael R. Grunwald, Venetia Bigley, Richard Dillon, Sylvie D. Freeman, Kathleen Gallagher, Amy Publicover, Sarah Pagan, Helen Marr, Gail L. Jones, Anne M. Dickinson, Angela Grech, Alan K. Burnett, Nigel H. Russell, Mark Levis, Steven Knapper, Matthew Collin
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3052–3061.
https://doi.org/10.1182/bloodadvances.2019000197
Published: 2019
Includes: Supplemental data